FDA Inspection 701726 — ARL Biopharma, Inc.
The FDA completed an inspection of ARL Biopharma, Inc. on November 19, 2010 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 19, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Oklahoma City, OK (United States)